Licensing Spironolatone for Acne in Women
Buyers
Value
£171,500
Classifications
- Health services
- Pharmacy services
Tags
- tender
Submission Deadline
2 weeks from now
Published
2 weeks ago
Description
NHS England requires a supplier to apply for a major (type II) MHRA Marketing Authorisation variation for spironolactone. The variation is to add a new indication to the current licence (marketing authorisation) for treating acne in women. The Successful Supplier would need to prepare a dossier for the MHRA including a Risk Management Plan, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data.<br/><br/>To register an interest in responding to this opportunity and obtain a copy of the tender documents please go to: http://health.atamis.co.uk. All communications and Request for Information submissions will be conducted via Atamis. The portal can be accessed at any time of the day and it is free to register.
Similar Contracts
Open
NHS Frimley Integrated Care Board
Published 1 day ago
Open
Hywel Dda University Health Board
Published 1 day ago
AI Bid Assistant
Our AI-powered tool to help you create winning bids is coming soon!
Timeline active
Evaluate
Award
Complete